Keros Therapeutics, Inc.

KROS Nasdaq SEC CIK 1664710

Follow Keros Therapeutics Weekly email: filings, results, news

News

3 stories filed under Keros Therapeutics, grouped into ongoing threads

Thread · 2 stories

Markets 22 d ago 3 sources

Markets 28 d ago

Markets 41 d ago also on TAK

NOV2

Q1 2026 results

Monday · estimated from the filing cadence

Profile · SEC EDGAR

Next results · estimated from the filing cadence (SEC EDGAR)

News · 3 stories clustered from the RSS aggregator